Chargement des cours...

Prévisions

Aucune donnée d'analyste n'est disponible pour cette entreprise.

Discussions dans la communauté

Il n'y a pas encore de discussion sur cet actif.

Lancer une discussion

  • Realbotix reports revenue decline ahead of launch of revised robot line

    Realbotix recorded a revenue decline in Q3 2026, which management mainly attributes to the end of its crypto-staking business and a change in revenue recognition for order backlogs. The company has completed its move to a new manufacturing facility and is preparing to launch a four-model robot line in the fall, including a tabletop model for $12,000 and a life-size model for about $55,000. Realbotix is also pursuing a listing via a transaction with Onconetix; an S-4 filing is expected shortly. Despite strong short-term liquidity (current ratio 5.8), the company shows a negative gross margin of -46% and declining annual revenues of $1.05m (down 46%), so the shift to commercialization and scaling direct sales will be critical for its future. » Plus sur de.investing.com


  • Realbotix humanoid robots show lifelike faces and humor but lack emotional awareness

    Realbotix builds expensive AI-powered humanoids with highly detailed silicone faces and dozens of motors to create realistic expressions. In tests the robots delivered surprising jokes and language flexibility, yet long response delays and poor recognition of users' emotions revealed limits in conversational naturalness. The company says it is still refining the technology as it sells early-generation models for applications like events and customer-facing roles. » Plus sur tech.yahoo.com


  • Realbotix bets on AI and robotics and aims for long-term growth

    Realbotix announced a strategic realignment toward AI and humanoid robotics in its Q2 earnings call, saying it has paid down all debt and secured operating capital for more than 12 months. Management does not expect short-term revenue growth; instead it presented a 3–4 year plan targeting quarterly revenue of $100 million. The company plans a Nasdaq listing via a reverse merger with Onco, cites supply bottlenecks for NVIDIA Thor processors as a risk, and currently values itself at around $55 million; the stock was trading near its 52-week low. » Plus sur de.investing.com


  • Realbotix bets on growth with debt-free balance sheet, new CFO and Aria robot

    Realbotix reports a strong cash position with no debt, has hired an experienced CFO and sold the domain Tokens.com for USD 2.5 million. The quarter was weak in revenue, but management expects rising sales through scaling, product expansion and delivery of around 15 robots in the next 2–3 months. Forecasts project revenue of USD 3 million (2026) and USD 12 million (2027) and EPS of −0.08 USD (2026) and 0.03 USD (2027). Risks remain low revenue volume, early commercialization stage, market skepticism toward humanoid robots and limited institutional access due to OTC listing. » Plus sur de.investing.com

Données fondamentales

Indicateur Valeur
Capitalisation boursière
25,87 M €
Nombre d'actions
219,94 M
Plus haut/bas sur 52 semaines
0,30 € - 0,11 €
Dividendes Non
Bêta
2,70
Ratio P/E
-
Ratio PEG
-
Ratio P/B
-
Ratio P/S
-

Profil de l'entreprise

Nom
Realbotix Aktie
PDG
Andrew Gabriel Kiguel
Siège social Toronto, on
Canada
Site web
Employés 99
🍪

Parqet  utilise des cookies. En savoir plus